Search

Search Constraints

You searched for: Author/Creator Moore, David H

Search Results

1. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Issue 10103 (7th October 2017)